These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3145875)

  • 1. In vitro evaluation of ramoplanin (MDL 62198, A 16686).
    Dixson S; Brumfitt W; Hamilton-Miller JM
    Eur J Clin Microbiol Infect Dis; 1988 Dec; 7(6):819-21. PubMed ID: 3145875
    [No Abstract]   [Full Text] [Related]  

  • 2. In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile.
    Bartoloni A; Colao MG; Orsi A; Dei R; Giganti E; Parenti F
    J Antimicrob Chemother; 1990 Nov; 26(5):627-33. PubMed ID: 1688341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activities of ramoplanin and four glycopeptide antibiotics against clinical isolates of Clostridium difficile.
    Biavasco F; Manso E; Varaldo PE
    Antimicrob Agents Chemother; 1991 Jan; 35(1):195-7. PubMed ID: 1826593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro studies with ramoplanin (MDL 62,198): a novel lipoglycopeptide antimicrobial.
    O'Hare MD; Ghosh G; Felmingham D; Grüneberg RN
    J Antimicrob Chemother; 1990 Feb; 25(2):217-20. PubMed ID: 2139436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of ramoplanin on staphylococci.
    Francis J; Webster H; Newsom SW
    Drugs Exp Clin Res; 1990; 16(9):457-60. PubMed ID: 2100247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ramoplanin. A 16686, a 16686a, MDL 62198.
    Drugs R D; 2002; 3(1):61-4. PubMed ID: 11881535
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro bactericidal activity of the glycopeptide compounds vancomycin, teicoplanin and ramoplanin (A-16686/MDL 62,198).
    O'Hare MD; Felmingham D; Grüneberg RN
    J Chemother; 1989 Jul; 1(4 Suppl):210-1. PubMed ID: 16312373
    [No Abstract]   [Full Text] [Related]  

  • 8. Ramoplanin: a review of its discovery and its chemistry.
    Parenti F; Ciabatti R; Cavalleri B; Kettenring J
    Drugs Exp Clin Res; 1990; 16(9):451-5. PubMed ID: 2100246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ramoplanin versus methicillin-resistant Staphylococcus aureus: in vitro experience.
    Brumfitt W; Maple PA; Hamilton-Miller JM
    Drugs Exp Clin Res; 1990; 16(8):377-83. PubMed ID: 2097143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of ramoplanin (A16686 or MDL62198). A new depsipeptide complex for potential topical use.
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1989; 12(3):279-82. PubMed ID: 2507218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in-vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin, DuP 721 and DuP 105 against methicillin and gentamicin resistant Staphylococcus aureus.
    Maple PA; Hamilton-Miller JM; Brumfitt W
    J Antimicrob Chemother; 1989 Apr; 23(4):517-25. PubMed ID: 2526111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total synthesis and examination of three key analogues of ramoplanin: a lipoglycodepsipeptide with potent antibiotic activity.
    Rew Y; Shin D; Hwang I; Boger DL
    J Am Chem Soc; 2004 Feb; 126(4):1041-3. PubMed ID: 14746470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro activity of ramoplanin (A-16686/MDL 62,198), vancomycin and teicoplanin against methicillin-susceptible and methicillin-resistant Staphylococcus spp.
    O'Hare MD; Felmingham D; Grüneberg RN
    Drugs Exp Clin Res; 1988; 14(10):617-9. PubMed ID: 2977587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of action of ramoplanin and enduracidin.
    Fang X; Tiyanont K; Zhang Y; Wanner J; Boger D; Walker S
    Mol Biosyst; 2006 Jan; 2(1):69-76. PubMed ID: 16880924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ramoplanin. A 16686, A 16686A, MDL 62198.
    Drugs R D; 2002; 3(4):271-5. PubMed ID: 12455203
    [No Abstract]   [Full Text] [Related]  

  • 16. Different broth dilution procedures generate different apparent MICs for ramoplanin.
    Bartoloni A; Mantella A; Goldstein BP; Denaro M; Paradisi F
    J Antimicrob Chemother; 1994 Jun; 33(6):1252-3. PubMed ID: 7928821
    [No Abstract]   [Full Text] [Related]  

  • 17. Dissecting ramoplanin: mechanistic analysis of synthetic ramoplanin analogues as a guide to the design of improved antibiotics.
    Chen L; Yuan Y; Helm JS; Hu Y; Rew Y; Shin D; Boger DL; Walker S
    J Am Chem Soc; 2004 Jun; 126(24):7462-3. PubMed ID: 15198592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of RP 59500 (quinupristin/dalfopristin) and ramoplanin against vancomycin-resistant Enterococcus faecium.
    Ristow TA; Noskin GA; Warren JR; Peterson LR
    Microb Drug Resist; 1995; 1(4):335-9. PubMed ID: 9158806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro activity of ramoplanin (a novel lipoglycopeptide), vancomycin, and teicoplanin against gram-positive clinical isolates from cancer patients.
    Rolston KV; Dholakia N; Ho DH; LeBlanc B; Dvorak T; Streeter H
    J Antimicrob Chemother; 1996 Aug; 38(2):265-9. PubMed ID: 8877541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the target sites and mechanisms of action of glycopeptide and lipoglycodepsipeptide antibiotics.
    Reynolds PE; Somner EA
    Drugs Exp Clin Res; 1990; 16(8):385-9. PubMed ID: 2151441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.